Dr Mark Prentice specialises in uro-oncology - prostate, bladder and renal cancers - and is interested in novel radiotherapy techniques, radio-ligand therapy, the hormonal manipulation of prostate cancer and the management of older people with cancer. He is the principal investigator for multiple clinical trials and has written international guidelines on prostate cancer management.